Evidence map›Paper›PMID 29483616›Full record

ArticleScientific reports2018

Pharmacological Mobilization of Endogenous Bone Marrow Stem Cells Promotes Liver Regeneration after Extensive Liver Resection in Rats.

Rujun Zhai, Yongchun Wang, Le Qi, George Melville Williams, Bin Gao, Guang Song, James F Burdick, Zhaoli Sun

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Induction of Skin Allograft Chimerism by Pharmacological Mobilization of Endogenous Bone Marrow-Derived Stem Cells.Journal of burn care & research : official publication of the American Burn Association · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Rujun ZhaiDepartment of Hepatobiliary Surgery, Tianjin Medical University Cancer Institute & Hospital and Tianjin Medical University Graduate School, Tianjin, P.R. China.
Yongchun WangDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Le QiDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
George Melville WilliamsDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Bin GaoLaboratory of Liver Disease, NIAAA/NIH, Rockville, MD, USA.
Guang SongDepartment of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
James F BurdickDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Zhaoli SunDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA. zsun2@jhmi.edu.
Johns Hopkins University · USJohns Hopkins Medicine · USNational Institutes of Health · USTianjin Medical University Cancer Institute and Hospital · CN

Funding

Alcoholic Liver Diseases: Damage, Repair and Stem Cell RegenerationU01AA018113 · NIAAA · JOHNS HOPKINS UNIVERSITY · PI SUN, ZHAOLI · 2010 to 2014
$1.8M
NIAAA NIH HHS U01 AA018113
6 · The paper itself

Abstract

Rapid regeneration of the remnant liver is critical for preventing liver failure and promoting recovery after extensive liver resection. Numerous studies have demonstrated the involvement of bone marrow-derived stem cells in liver regeneration and the potential benefits of bone marrow stem cell therapy. To avoid the preparation of stem cells, we proposed in this study to mobilize endogenous bone marrow stem cells pharmacologically with a combination of AMD3100 (A), an antagonist of CXCR4 and low-dose FK506 (F). Here we show that AF combination therapy significantly increased lineage negative (Lin-) CD34+ and Lin-CD133+ stem cells in peripheral blood and enhanced recruitment of CD133+ cells into the remnant liver in a rat model of 85% partial hepatectomy. Recruiting CD133+ stem cells in the remnant liver was associated with increased proliferation of hepatic oval cells and paralleled the increased SDF-1, CXCR4 and HGF expression. Importantly, AF combination therapy increased the number of Ki67 positive hepatocytes and BrdU incorporation in the remnant liver and improved serum levels of albumin. Our results demonstrate that pharmacological mobilization of endogenous bone marrow stem cells with AF combination therapy can enhance endogenous stem cell mobilization to promote liver regeneration and improve liver function after extensive hepatectomy.

Indexed as

AC133 AntigenAlanine TransaminaseAnimalsAntigens, CD34Aspartate AminotransferasesBenzylaminesBone Marrow CellsCalcineurin InhibitorsCell ProliferationChemokine CXCL12CyclamsDrug Therapy, CombinationFemaleHematopoietic Stem Cell MobilizationHepatectomyHepatocyte Growth FactorAC133 AntigenAlanine TransaminaseAntigens, CD34Aspartate AminotransferasesBenzylaminesCalcineurin InhibitorsChemokine CXCL12CXCL12 protein, ratCxcr4 protein, ratCyclamsHepatocyte Growth FactorHeterocyclic CompoundsplerixaforProm1 protein, ratReceptors, CXCR4Serum AlbuminTacrolimus

Identifiers

PMID29483616
PMCPMC5827664
OpenAlexW2806447595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.